U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 1364

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr22:30038230
GRCh38:
Chr22:29642241
NF2P135S, P52S, P58S, P93S, P94S, P97SNeurofibromatosis, type 2Uncertain significance
(Dec 2, 2022)
criteria provided, single submitter
2.
GRCh37:
Chr22:30051572
GRCh38:
Chr22:29655583
NF2Neurofibromatosis, type 2Likely benign
(Sep 13, 2022)
criteria provided, single submitter
3.
GRCh37:
Chr22:30074175-30090791
NF2Neurofibromatosis, type 2Uncertain significance
(Nov 6, 2021)
criteria provided, single submitter
4.
GRCh37:
Chr22:30050636-30051675
NF2Neurofibromatosis, type 2Pathogenic
(Aug 30, 2022)
criteria provided, single submitter
5.
GRCh37:
Chr22:30032730-30064445
NF2Neurofibromatosis, type 2Pathogenic
(Jul 21, 2022)
criteria provided, single submitter
6.
GRCh37:
Chr22:30077418-30090791
NF2Neurofibromatosis, type 2Pathogenic
(Oct 19, 2021)
criteria provided, single submitter
7.
GRCh37:
Chr22:30074175-30077600
NF2Neurofibromatosis, type 2Likely pathogenic
(Sep 19, 2022)
criteria provided, single submitter
8.
GRCh37:
Chr22:30070815-30077600
NF2Neurofibromatosis, type 2Pathogenic
(Apr 11, 2022)
criteria provided, single submitter
9.
GRCh37:
Chr22:30077429
GRCh38:
Chr22:29681440
NF2V348M, V440M, V443M, V449M, V481M, V484M, V485M, V488M, V526MNeurofibromatosis, type 2Uncertain significance
(Jul 27, 2022)
criteria provided, single submitter
10.
GRCh37:
Chr22:30077604
GRCh38:
Chr22:29681615
NF2Neurofibromatosis, type 2Likely benign
(Aug 10, 2022)
criteria provided, single submitter
11.
GRCh37:
Chr22:30077461
GRCh38:
Chr22:29681472
NF2Q358H, Q450H, Q453H, Q459H, Q491H, Q494H, Q495H, Q498H, Q536HNeurofibromatosis, type 2Uncertain significance
(Jan 15, 2022)
criteria provided, single submitter
12.
GRCh37:
Chr22:30032777
GRCh38:
Chr22:29636788
NF2C13F, C51FNeurofibromatosis, type 2Uncertain significance
(May 26, 2022)
criteria provided, single submitter
13.
GRCh37:
Chr22:30069251
GRCh38:
Chr22:29673262
NF2Neurofibromatosis, type 2Likely benign
(Dec 7, 2021)
criteria provided, single submitter
14.
GRCh37:
Chr22:30069480
GRCh38:
Chr22:29673491
NF2Neurofibromatosis, type 2Uncertain significance
(Aug 18, 2022)
criteria provided, single submitter
15.
GRCh37:
Chr22:30050713
GRCh38:
Chr22:29654724
NF2R89M, R134M, R172M, R130M, R131M, R95MNeurofibromatosis, type 2, Inborn genetic diseasesUncertain significance
(Jun 9, 2022)
criteria provided, multiple submitters, no conflicts
16.
GRCh37:
Chr22:30067904
GRCh38:
Chr22:29671915
NF2M280I, M321I, M325I, M318I, M277I, M286I, M322I, M185I, M363INeurofibromatosis, type 2Uncertain significance
(May 29, 2022)
criteria provided, single submitter
17.
GRCh37:
Chr22:30032722
GRCh38:
Chr22:29636733
NF2Neurofibromatosis, type 2Likely benign
(May 21, 2022)
criteria provided, single submitter
18.
GRCh37:
Chr22:30070883
GRCh38:
Chr22:29674894
NF2R384G, R429G, R467G, R390G, R422G, R289G, R381G, R426G, R425GNeurofibromatosis, type 2Uncertain significance
(Jul 30, 2022)
criteria provided, single submitter
19.
GRCh37:
Chr22:30032842
GRCh38:
Chr22:29636853
NF2A73T, A35TNeurofibromatosis, type 2Uncertain significance
(Aug 22, 2022)
criteria provided, single submitter
20.
GRCh37:
Chr22:30051682
GRCh38:
Chr22:29655693
NF2Neurofibromatosis, type 2Likely benign
(Aug 3, 2022)
criteria provided, single submitter
21.
GRCh37:
Chr22:30035215
GRCh38:
Chr22:29639226
NF2Neurofibromatosis, type 2Likely benign
(Sep 19, 2022)
criteria provided, single submitter
22.
GRCh37:
Chr22:30067813
GRCh38:
Chr22:29671824
NF2Neurofibromatosis, type 2Likely pathogenic
(Apr 25, 2022)
criteria provided, single submitter
23.
GRCh37:
Chr22:30069249
GRCh38:
Chr22:29673260
NF2Neurofibromatosis, type 2Likely benign
(Aug 24, 2022)
criteria provided, single submitter
24.
GRCh37:
Chr22:30000074
GRCh38:
Chr22:29604085
NF2M29INeurofibromatosis, type 2Uncertain significance
(Sep 26, 2022)
criteria provided, single submitter
25.
GRCh37:
Chr22:30050666
GRCh38:
Chr22:29654677
NF2Neurofibromatosis, type 2Likely benign
(Jul 29, 2022)
criteria provided, single submitter
26.
GRCh37:
Chr22:30032773
GRCh38:
Chr22:29636784
NF2V12M, V50MNeurofibromatosis, type 2Uncertain significance
(Jul 12, 2022)
criteria provided, single submitter
27.
GRCh37:
Chr22:30074293
GRCh38:
Chr22:29678304
NF2M341V, M436V, M442V, M478V, M433V, M519V, M474V, M477V, M481VNeurofibromatosis, type 2, Hereditary cancer-predisposing syndromeUncertain significance
(Dec 20, 2022)
criteria provided, multiple submitters, no conflicts
28.
GRCh37:
Chr22:30077462
GRCh38:
Chr22:29681473
NF2E359K, E454K, E499K, E451K, E495K, E460K, E492K, E496K, E537KNeurofibromatosis, type 2Uncertain significance
(Feb 13, 2022)
criteria provided, single submitter
29.
GRCh37:
Chr22:30032878
GRCh38:
Chr22:29636889
NF2Neurofibromatosis, type 2Likely benign
(Jun 20, 2022)
criteria provided, single submitter
30.
GRCh37:
Chr22:30035065
GRCh38:
Chr22:29639076
NF2Neurofibromatosis, type 2Likely benign
(Jul 13, 2022)
criteria provided, single submitter
31.
GRCh37:
Chr22:30032754
GRCh38:
Chr22:29636765
NF2Neurofibromatosis, type 2Likely benign
(Apr 1, 2022)
criteria provided, single submitter
32.
GRCh37:
Chr22:30069265
GRCh38:
Chr22:29673276
NF2S199C, S300C, S335C, S336C, S377C, S291C, S294C, S332C, S339CNeurofibromatosis, type 2Uncertain significance
(Aug 23, 2022)
criteria provided, single submitter
33.
GRCh37:
Chr22:30069480
GRCh38:
Chr22:29673491
NF2Neurofibromatosis, type 2Uncertain significance
(Apr 19, 2022)
criteria provided, single submitter
34.
GRCh37:
Chr22:30060965
GRCh38:
Chr22:29664976
NF2Neurofibromatosis, type 2Likely benign
(Sep 10, 2022)
criteria provided, single submitter
35.
GRCh37:
Chr22:30077542
GRCh38:
Chr22:29681553
NF2Neurofibromatosis, type 2Likely benign
(Sep 7, 2022)
criteria provided, single submitter
36.
GRCh37:
Chr22:30069391
GRCh38:
Chr22:29673402
NF2T378R, T241R, T333R, T336R, T419R, T342R, T374R, T377R, T381RNeurofibromatosis, type 2Uncertain significance
(Oct 23, 2022)
criteria provided, single submitter
37.
GRCh37:
Chr22:30035062
GRCh38:
Chr22:29639073
NF2Neurofibromatosis, type 2Likely benign
(Oct 2, 2022)
criteria provided, single submitter
38.
GRCh37:
Chr22:30069459
GRCh38:
Chr22:29673470
NF2E264K, E356K, E365K, E359K, E400K, E442K, E397K, E401K, E404KNeurofibromatosis, type 2Uncertain significance
(Aug 27, 2022)
criteria provided, single submitter
39.
GRCh37:
Chr22:30064333
GRCh38:
Chr22:29668344
NF2Neurofibromatosis, type 2Likely benign
(Feb 9, 2022)
criteria provided, single submitter
40.
GRCh37:
Chr22:30035079
GRCh38:
Chr22:29639090
NF2V81I, V43I, V39I, V4INeurofibromatosis, type 2Uncertain significance
(Apr 22, 2022)
criteria provided, single submitter
41.
GRCh37:
Chr22:30035197
GRCh38:
Chr22:29639208
NF2L82S, L43S, L120S, L78SNeurofibromatosis, type 2Uncertain significance
(Feb 10, 2022)
criteria provided, single submitter
42.
GRCh37:
Chr22:30035129
GRCh38:
Chr22:29639140
NF2Neurofibromatosis, type 2Likely benign
(Feb 20, 2022)
criteria provided, single submitter
43.
GRCh37:
Chr22:30000120
GRCh38:
Chr22:29604131
NF2Neurofibromatosis, type 2Likely benign
(Oct 15, 2022)
criteria provided, single submitter
44.
GRCh37:
Chr22:30035123
GRCh38:
Chr22:29639134
NF2Neurofibromatosis, type 2Likely benign
(Jul 20, 2022)
criteria provided, single submitter
45.
GRCh37:
Chr22:30067832
GRCh38:
Chr22:29671843
NF2Neurofibromatosis, type 2Likely benign
(Mar 25, 2022)
criteria provided, single submitter
46.
GRCh37:
Chr22:30050667
GRCh38:
Chr22:29654678
NF2V116L, V74L, V80L, V119L, V157L, V115LNeurofibromatosis, type 2Uncertain significance
(May 19, 2022)
criteria provided, single submitter
47.
GRCh37:
Chr22:30077478
GRCh38:
Chr22:29681489
NF2L364H, L456H, L500H, L459H, L465H, L501H, L542H, L497H, L504HNeurofibromatosis, type 2Uncertain significance
(May 11, 2022)
criteria provided, single submitter
48.
GRCh37:
Chr22:30074301-30074304
GRCh38:
Chr22:29678312-29678315
NF2E439fs, E481fs, E480fs, E522fsNeurofibromatosis, type 2Pathogenic
(Mar 21, 2022)
criteria provided, single submitter
49.
GRCh37:
Chr22:30067899
GRCh38:
Chr22:29671910
NF2Q184*, Q276*, Q285*, Q321*, Q279*, Q317*, Q320*, Q362*, Q324*Neurofibromatosis, type 2Pathogenic
(Mar 2, 2022)
criteria provided, single submitter
50.
GRCh37:
Chr22:30057323
GRCh38:
Chr22:29661334
NF2K186*, K227*, K228*, K192*, K269*, K91*, K231*Neurofibromatosis, type 2Pathogenic
(May 19, 2022)
criteria provided, single submitter
51.
GRCh37:
Chr22:30057193
GRCh38:
Chr22:29661204
NF2Neurofibromatosis, type 2Pathogenic
(May 14, 2022)
criteria provided, single submitter
52.
GRCh37:
Chr22:30054258
GRCh38:
Chr22:29658269
NF2Neurofibromatosis, type 2Uncertain significance
(Sep 17, 2022)
criteria provided, single submitter
53.
GRCh37:
Chr22:30035107
GRCh38:
Chr22:29639118
NF2E48fs, E90fsNeurofibromatosis, type 2Pathogenic
(Jul 26, 2022)
criteria provided, single submitter
54.
GRCh37:
Chr22:30077529
GRCh38:
Chr22:29681540
NF2D559fs, D518fs, D476fs, D517fsNeurofibromatosis, type 2Uncertain significance
(Sep 13, 2022)
criteria provided, single submitter
55.
GRCh37:
Chr22:30032784
GRCh38:
Chr22:29636795
NF2Neurofibromatosis, type 2Likely benign
(May 1, 2022)
criteria provided, single submitter
56.
GRCh37:
Chr22:30038278
GRCh38:
Chr22:29642289
NF2Neurofibromatosis, type 2Uncertain significance
(Apr 15, 2022)
criteria provided, single submitter
57.
GRCh37:
Chr22:30070906
GRCh38:
Chr22:29674917
NF2E388D, E432D, E296D, E397D, E436D, E391D, E429D, E433D, E474DNeurofibromatosis, type 2Uncertain significance
(Apr 8, 2022)
criteria provided, single submitter
58.
GRCh37:
Chr22:30064450
GRCh38:
Chr22:29668461
NF2Neurofibromatosis, type 2Likely benign
(Apr 2, 2022)
criteria provided, single submitter
59.
GRCh37:
Chr22:30077486
GRCh38:
Chr22:29681497
NF2E462K, E545K, E459K, E500K, E507K, E503K, E367K, E468K, E504KNeurofibromatosis, type 2Uncertain significance
(Mar 29, 2022)
criteria provided, single submitter
60.
GRCh37:
Chr22:30051658-30051981
GRCh38:
Chr22:29655669-29655992
NF2Neurofibromatosis, type 2Likely pathogenic
(Mar 18, 2022)
criteria provided, single submitter
61.
GRCh37:
Chr22:30035212
GRCh38:
Chr22:29639223
NF2Neurofibromatosis, type 2Likely benign
(Mar 13, 2022)
criteria provided, single submitter
62.
GRCh37:
Chr22:30069306
GRCh38:
Chr22:29673317
NF2T213S, T391S, T346S, T353S, T305S, T308S, T314S, T349S, T350SNeurofibromatosis, type 2Uncertain significance
(Mar 11, 2022)
criteria provided, single submitter
63.
GRCh37:
Chr22:30074245
GRCh38:
Chr22:29678256
NF2D417N, D420N, D503N, D462N, D325N, D458N, D426N, D461N, D465NNeurofibromatosis, type 2Uncertain significance
(Apr 24, 2022)
criteria provided, single submitter
64.
GRCh37:
Chr22:30000105-30000106
GRCh38:
Chr22:29604116-29604117
NF2Neurofibromatosis, type 2Likely benign
(Mar 8, 2022)
criteria provided, single submitter
65.
GRCh37:
Chr22:30057264
GRCh38:
Chr22:29661275
NF2R172K, R249K, R166K, R211K, R207K, R208K, R71KNeurofibromatosis, type 2Uncertain significance
(Aug 24, 2022)
criteria provided, single submitter
66.
GRCh37:
Chr22:30070889
GRCh38:
Chr22:29674900
NF2K291Q, K383Q, K428Q, K427Q, K469Q, K386Q, K392Q, K424Q, K431QNeurofibromatosis, type 2Uncertain significance
(Mar 3, 2022)
criteria provided, single submitter
67.
GRCh37:
Chr22:30035079-30035087
GRCh38:
Chr22:29639090-29639098
NF2V39fs, V81fsNeurofibromatosis, type 2Pathogenic
(Mar 1, 2022)
criteria provided, single submitter
68.
GRCh37:
Chr22:30035166
GRCh38:
Chr22:29639177
NF2V33I, V68I, V72I, V110INeurofibromatosis, type 2Uncertain significance
(Feb 23, 2022)
criteria provided, single submitter
69.
GRCh37:
Chr22:30069411
GRCh38:
Chr22:29673422
NF2M340V, M349V, M384V, M385V, M343V, M381V, M388V, M426V, M248VNeurofibromatosis, type 2Uncertain significance
(May 14, 2022)
criteria provided, single submitter
70.
GRCh37:
Chr22:30077483
GRCh38:
Chr22:29681494
NF2T458P, T366P, T461P, T502P, T506P, T467P, T499P, T503P, T544PNeurofibromatosis, type 2Uncertain significance
(Feb 9, 2022)
criteria provided, single submitter
71.
GRCh37:
Chr22:30067895-30067896
GRCh38:
Chr22:29671906-29671907
NF2Neurofibromatosis, type 2Likely benign
(Feb 7, 2022)
criteria provided, single submitter
72.
GRCh37:
Chr22:30074242
GRCh38:
Chr22:29678253
NF2G419S, G425S, G457S, G460S, G324S, G416S, G502S, G461S, G464SNeurofibromatosis, type 2Uncertain significance
(Jan 28, 2022)
criteria provided, single submitter
73.
GRCh37:
Chr22:30069338
GRCh38:
Chr22:29673349
NF2K223N, K363N, K359N, K360N, K401N, K315N, K318N, K324N, K356NNeurofibromatosis, type 2, Hereditary cancer-predisposing syndromeUncertain significance
(Nov 3, 2022)
criteria provided, multiple submitters, no conflicts
74.
GRCh37:
Chr22:30090727
GRCh38:
Chr22:29694738
NF2Neurofibromatosis, type 2Likely benign
(Jan 18, 2022)
criteria provided, single submitter
75.
GRCh37:
Chr22:30077418
GRCh38:
Chr22:29681429
NF2Neurofibromatosis, type 2Likely benign
(May 31, 2022)
criteria provided, single submitter
76.
GRCh37:
Chr22:30070950
GRCh38:
Chr22:29674961
NF2Neurofibromatosis, type 2Likely benign
(Aug 16, 2022)
criteria provided, single submitter
77.
GRCh37:
Chr22:30074242
GRCh38:
Chr22:29678253
NF2G419C, G457C, G464C, G502C, G416C, G461C, G324C, G425C, G460CNeurofibromatosis, type 2Uncertain significance
(Jul 26, 2022)
criteria provided, single submitter
78.
GRCh37:
Chr22:30077543
GRCh38:
Chr22:29681554
NF2E478K, E487K, E564K, E481K, E519K, E522K, E386K, E523K, E526KNeurofibromatosis, type 2Uncertain significance
(Sep 14, 2022)
criteria provided, single submitter
79.
GRCh37:
Chr22:30074328
GRCh38:
Chr22:29678339
NF2Neurofibromatosis, type 2Likely benign
(Oct 26, 2022)
criteria provided, single submitter
80.
GRCh37:
Chr22:30032720-30032721
GRCh38:
Chr22:29636731-29636732
NF2Neurofibromatosis, type 2Uncertain significance
(Mar 29, 2022)
criteria provided, single submitter
81.
GRCh37:
Chr22:30069430
GRCh38:
Chr22:29673441
NF2E355G, E387G, E394G, E254G, E432G, E346G, E349G, E390G, E391GNeurofibromatosis, type 2Uncertain significance
(Jan 2, 2022)
criteria provided, single submitter
82.
GRCh37:
Chr22:30051654
GRCh38:
Chr22:29655665
NF2Neurofibromatosis, type 2Likely benign
(Jan 2, 2022)
criteria provided, single submitter
83.
GRCh37:
Chr22:30051675
GRCh38:
Chr22:29655686
NF2Neurofibromatosis, type 2Likely benign
(Sep 12, 2022)
criteria provided, single submitter
84.
GRCh37:
Chr22:30069488
GRCh38:
Chr22:29673499
NF2Neurofibromatosis, type 2Likely benign
(Oct 16, 2022)
criteria provided, single submitter
85.
GRCh37:
Chr22:30035162
GRCh38:
Chr22:29639173
NF2Neurofibromatosis, type 2Likely benign
(Oct 1, 2022)
criteria provided, single submitter
86.
GRCh37:
Chr22:30051571
GRCh38:
Chr22:29655582
NF2Neurofibromatosis, type 2Likely benign
(Dec 21, 2021)
criteria provided, single submitter
87.
GRCh37:
Chr22:30057342
GRCh38:
Chr22:29661353
NF2Neurofibromatosis, type 2Likely benign
(Sep 20, 2022)
criteria provided, single submitter
88.
GRCh37:
Chr22:30000048
GRCh38:
Chr22:29604059
NF2T21ANeurofibromatosis, type 2Uncertain significance
(Aug 26, 2022)
criteria provided, single submitter
89.
GRCh37:
Chr22:30069337
GRCh38:
Chr22:29673348
NF2K223R, K318R, K356R, K359R, K401R, K315R, K324R, K363R, K360RNeurofibromatosis, type 2Uncertain significance
(Dec 24, 2021)
criteria provided, single submitter
90.
GRCh37:
Chr22:30000112
GRCh38:
Chr22:29604123
NF2Neurofibromatosis, type 2Likely benign
(Oct 12, 2022)
criteria provided, single submitter
91.
GRCh37:
Chr22:30069363-30069364
GRCh38:
Chr22:29673374-29673375
NF2R328fs, R369fs, R370fs, R411fsNeurofibromatosis, type 2Pathogenic
(Dec 23, 2021)
criteria provided, single submitter
92.
GRCh37:
Chr22:30050709
GRCh38:
Chr22:29654720
NF2K129E, K171E, K130E, K94E, K133E, K88ENeurofibromatosis, type 2Uncertain significance
(Jun 14, 2022)
criteria provided, single submitter
93.
GRCh37:
Chr22:30070947
GRCh38:
Chr22:29674958
NF2Neurofibromatosis, type 2Likely benign
(Jul 9, 2022)
criteria provided, single submitter
94.
GRCh37:
Chr22:30077411
GRCh38:
Chr22:29681422
NF2Neurofibromatosis, type 2Likely benign
(Feb 3, 2022)
criteria provided, single submitter
95.
GRCh37:
Chr22:30067858
GRCh38:
Chr22:29671869
NF2E262V, E271V, E170V, E306V, E307V, E310V, E348V, E265V, E303VNeurofibromatosis, type 2Uncertain significance
(Dec 20, 2021)
criteria provided, single submitter
96.
GRCh37:
Chr22:30074165
GRCh38:
Chr22:29678176
NF2Neurofibromatosis, type 2Likely benign
(Oct 20, 2022)
criteria provided, single submitter
97.
GRCh37:
Chr22:30000036
GRCh38:
Chr22:29604047
NF2K17ENeurofibromatosis, type 2Uncertain significance
(Dec 24, 2021)
criteria provided, single submitter
98.
GRCh37:
Chr22:30070852
GRCh38:
Chr22:29674863
NF2Neurofibromatosis, type 2, Hereditary cancer-predisposing syndromeLikely benign
(Mar 12, 2023)
criteria provided, multiple submitters, no conflicts
99.
GRCh37:
Chr22:30090756-30090770
GRCh38:
Chr22:29694767-29694781
NF2Neurofibromatosis, type 2Uncertain significance
(Jul 19, 2022)
criteria provided, single submitter
100.
GRCh37:
Chr22:30067903
GRCh38:
Chr22:29671914
NF2M185T, M277T, M280T, M318T, M325T, M321T, M286T, M322T, M363TNeurofibromatosis, type 2Uncertain significance
(Dec 22, 2021)
criteria provided, single submitter
Format
Items per page
Sort by
Choose Destination